Approved Asthma Therapy Omalizumab Reduces SLE Disease Activity, Phase 1b Trial Finds January 14, 2019Approved Asthma Therapy Omalizumab Reduces SLE Disease Activity, Phase 1b Trial Finds Approved Asthma Therapy Omalizumab Reduces SLE Disease Activity, Phase 1b Trial Finds
